# Bayer Roundup litigation and settlement efforts

> Live situation record from CLSTR: https://clstr.news/situations/bayer-roundup-litigation-and-settlement-efforts
> Updated: 2026-09-14T08:59:47.000Z. Sources: 8. Developments: 3.

Bayer continues to face legal and financial challenges regarding its herbicide Roundup and allegations that its active ingredient, glyphosate, causes non-Hodgkin lymphoma.

In the United States, a Missouri court is conducting a fairness hearing regarding a proposed $7.25 billion settlement. While previous estimates addressed approximately 65,000 claims, the current settlement aims to resolve litigation involving approximately 197,000 Americans. If approved, the deal would provide between $10,000 and $165,000 for affected individuals. 

However, the settlement faces opposition from some plaintiffs’ attorneys who have characterized the deal as a ‘collusive arrangement.’ These objectors argue that the framework provides significant fees to attorneys while offering relatively small payouts to victims. They have also criticized the settlement for allowing Bayer to continue selling the product without cancer warnings and for limiting future punitive damages through a 20-year claims period. Bayer maintains that glyphosate is safe and denies all allegations of wrongdoing.

In Chile, the legal battle has taken a different turn. The Supreme Court rejected a cassation appeal by the Organization of Consumers and Users (ODECU), ending a five-year class action lawsuit against Bayer and Arysta LifeScience. Following the dismissal, ODECU has called on Bayer to voluntarily implement compensation and assistance mechanisms for affected individuals, similar to the programs established by the company in the United States.

## Claims

- Judge Timothy Boyer called a fairness hearing to address complaints regarding the proposed settlement. (single source)
- The proposed settlement for Roundup cancer litigation is valued at $7.25 billion. (single source)
- Individual cancer victims could receive between $10,000 and $165,000 under the settlement. (single source)
- Approximately 197,000 Americans had filed lawsuits against Bayer. (single source)
- The settlement includes $675 million in fees for the attorneys involved. (single source)
- The settlement would allow Bayer to continue selling glyphosate-based weed killers. (single source)

## Timeline

### 2026-09-14: Bayer glyphosate settlement faces US court fairness hearing

A Missouri court is reviewing a proposed $7.25 billion settlement by Bayer to resolve Roundup glyphosate litigation involving nearly 200,000 claimants.

4 sources. https://clstr.news/cluster/bayer-shares-rise-ahead-of-us-roundup-settlement-hearing

### 2026-09-11: Bayer seeks approval for $7.25 billion Roundup settlement

Bayer seeks court approval for a $7.25 billion settlement to resolve tens of thousands of U.S. lawsuits alleging Roundup causes non-Hodgkin lymphoma, with individual payouts varying by severity.

2 sources. https://clstr.news/cluster/bayer-seeks-approval-for-725-billion-roundup-settlement

### 2026-08-26: Bayer faces calls for voluntary compensation after Chile court rejects Roundup lawsuit

Chile's Supreme Court dismissed a class action lawsuit against Bayer and Arysta regarding Roundup's alleged links to cancer, prompting consumer advocates to call for voluntary compensation models.

2 sources. https://clstr.news/cluster/bayer-faces-calls-for-voluntary-compensation-after-chile-court-rejects-roundup-lawsuit

---
Cite as: Bayer Roundup litigation and settlement efforts. CLSTR, https://clstr.news/situations/bayer-roundup-litigation-and-settlement-efforts